(AASLD) The Liver Meeting® 2026 - Oral Presentation
Nov 09, 2026 at 10:30 AM MST
Session: Late-Breaker Session 3
Abstract Title: Efficacy and Safety of Pemvidutide in the Treatment of Adults with Alcohol Use Disorder: Results from RECLAIM, a 24-Week Phase 2 Randomized Double-Blind Placebo-Controlled Trial
Speaker: Henry R. Kranzler, M.D.
